• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

OCT4 作为 miR-34a 的靶标,可刺激 p63 但抑制 p53,从而促进人细胞转化。

OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation.

机构信息

Department of Radiation Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, GA, USA.

Division of Space Life Sciences, Universities Space Research Association, Houston, TX, USA.

出版信息

Cell Death Dis. 2014 Jan 23;5(1):e1024. doi: 10.1038/cddis.2013.563.

DOI:10.1038/cddis.2013.563
PMID:24457968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4040665/
Abstract

Human cell transformation is a key step for oncogenic development, which involves multiple pathways; however, the mechanism remains unclear. To test our hypothesis whether cell oncogenic transformation shares some mechanisms with the process of reprogramming non-stem cells to induced pluripotent stem cells (iPSC), we studied the relationship among the key factors for promoting or inhibiting iPSC in radiation-transformed human epithelial cell lines derived from different tissues (lung, breast and colon). We unexpectedly found that p63 and OCT4 were highly expressed (accompanied by low expressed p53 and miR-34a) in all transformed cell lines examined when compared with their non-transformed counterparts. We further elucidated the relationship of these factors: the 3p strand of miR-34a directly targeted OCT4 by binding to the 3' untranslated region (3'-UTR) of OCT4 and, OCT4, in turn, stimulated p63 but inhibited p53 expression by binding to a specific region of the p63 or p53 promoter. Moreover, we revealed that the effects of OCT4 on promoting cell oncogenic transformation were by affecting p63 and p53. These results support that a positive loop exists in human cells: OCT4 upregulation as a consequence of inhibition of miR-34a, promotes p63 but suppresses p53 expression, which further stimulates OCT4 upregulation by downregulating miR-34a. This functional loop contributes significantly to cell transformation and, most likely, also to the iPSC process.

摘要

人类细胞转化是致癌发展的关键步骤,涉及多个途径;然而,其机制尚不清楚。为了验证我们的假设,即细胞致癌转化是否与将非干细胞重编程为诱导多能干细胞(iPSC)的过程共享一些机制,我们研究了促进或抑制源自不同组织(肺、乳腺和结肠)的辐射转化人上皮细胞系中 iPSC 的关键因素之间的关系。我们出人意料地发现,与未转化的细胞相比,所有转化细胞系中 p63 和 OCT4 的表达水平均升高(同时伴有低表达的 p53 和 miR-34a)。我们进一步阐明了这些因素之间的关系:miR-34a 的 3p 链通过与 OCT4 的 3'非翻译区(3'-UTR)结合而直接靶向 OCT4,而 OCT4 则通过结合 p63 或 p53 启动子的特定区域来刺激 p63 但抑制 p53 表达。此外,我们揭示了 OCT4 对促进细胞致癌转化的影响是通过影响 p63 和 p53 实现的。这些结果支持人细胞中存在正反馈环:miR-34a 抑制的结果是 OCT4 的上调,促进了 p63 的表达,但抑制了 p53 的表达,这进一步通过下调 miR-34a 来刺激 OCT4 的上调。这个功能环对细胞转化有重要贡献,很可能对 iPSC 过程也有重要贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3768/4040665/7d6e9b9f17ed/cddis2013563f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3768/4040665/623f6d2eb263/cddis2013563f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3768/4040665/b310f3dafb23/cddis2013563f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3768/4040665/4311b9612019/cddis2013563f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3768/4040665/e38bccdc8703/cddis2013563f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3768/4040665/7d6e9b9f17ed/cddis2013563f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3768/4040665/623f6d2eb263/cddis2013563f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3768/4040665/b310f3dafb23/cddis2013563f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3768/4040665/4311b9612019/cddis2013563f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3768/4040665/e38bccdc8703/cddis2013563f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3768/4040665/7d6e9b9f17ed/cddis2013563f5.jpg

相似文献

1
OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation.OCT4 作为 miR-34a 的靶标,可刺激 p63 但抑制 p53,从而促进人细胞转化。
Cell Death Dis. 2014 Jan 23;5(1):e1024. doi: 10.1038/cddis.2013.563.
2
miR-34 miRNAs provide a barrier for somatic cell reprogramming.miR-34 miRNAs 为体细胞重编程提供了一道屏障。
Nat Cell Biol. 2011 Oct 23;13(11):1353-60. doi: 10.1038/ncb2366.
3
MicroRNA-302 increases reprogramming efficiency via repression of NR2F2.MicroRNA-302 通过抑制 NR2F2 提高重编程效率。
Stem Cells. 2013 Feb;31(2):259-68. doi: 10.1002/stem.1278.
4
Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells.Oct4/Sox2调控的miR-302靶向人类胚胎干细胞中的细胞周期蛋白D1。
Mol Cell Biol. 2008 Oct;28(20):6426-38. doi: 10.1128/MCB.00359-08. Epub 2008 Aug 18.
5
MiR-138 promotes induced pluripotent stem cell generation through the regulation of the p53 signaling.miR-138 通过调节 p53 信号促进诱导多能干细胞生成。
Stem Cells. 2012 Aug;30(8):1645-54. doi: 10.1002/stem.1149.
6
Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation.在 Oct4/Sox2 诱导的间充质到上皮转化和诱导多能干细胞生成中,miR-200/ZEB2 通路的关键调控。
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2858-63. doi: 10.1073/pnas.1212769110. Epub 2013 Feb 5.
7
Human fibroblast reprogramming to pluripotent stem cells regulated by the miR19a/b-PTEN axis.由miR19a/b-PTEN轴调控的人成纤维细胞重编程为多能干细胞。
PLoS One. 2014 Apr 16;9(4):e95213. doi: 10.1371/journal.pone.0095213. eCollection 2014.
8
Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells.Δ133p53抑制p53诱导的衰老基因,并增强人类诱导多能干细胞的生成。
Cell Death Differ. 2017 Jun;24(6):1017-1028. doi: 10.1038/cdd.2017.48. Epub 2017 Mar 31.
9
p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells.p53 通过调控细胞周期和 microRNAs 促进人胚胎干细胞的分化。
PLoS Biol. 2012;10(2):e1001268. doi: 10.1371/journal.pbio.1001268. Epub 2012 Feb 28.
10
miR-129 targets CDK1 and iASPP to modulate Burkitt lymphoma cell proliferation in a TAp63-dependent manner.miR-129 通过靶向 CDK1 和 iASPP 以 TAp63 依赖的方式调节伯基特淋巴瘤细胞增殖。
J Cell Biochem. 2018 Nov;119(11):9217-9228. doi: 10.1002/jcb.27189. Epub 2018 Aug 13.

引用本文的文献

1
E47 upregulates ΔNp63α to promote growth of squamous cell carcinoma.E47 通过上调 ΔNp63α 促进鳞状细胞癌的生长。
Cell Death Dis. 2021 Apr 8;12(4):381. doi: 10.1038/s41419-021-03662-3.
2
Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma by Vitamin D Compounds.转录组分析:维生素 D 化合物对乳腺导管癌肿瘤干细胞特性的调控。
Cancer Prev Res (Phila). 2020 Aug;13(8):673-686. doi: 10.1158/1940-6207.CAPR-19-0566. Epub 2020 May 28.
3
Transcription Factor and miRNA Interplays Can Manifest the Survival of ccRCC Patients.

本文引用的文献

1
miRNA profiling of cancer.癌症的 miRNA 分析。
Curr Opin Genet Dev. 2013 Feb;23(1):3-11. doi: 10.1016/j.gde.2013.01.004. Epub 2013 Mar 4.
2
ΔNp63α represses anti-proliferative genes via H2A.Z deposition.ΔNp63α 通过 H2A.Z 沉积抑制抗增殖基因。
Genes Dev. 2012 Oct 15;26(20):2325-36. doi: 10.1101/gad.198069.112. Epub 2012 Sep 26.
3
miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.miRNA-34 可预防治疗抵抗的 K-ras 和 p53 诱导的肺腺癌细胞癌发生和进展的小鼠模型中的癌症发生和进展。
转录因子与微小RNA的相互作用能够体现肾透明细胞癌患者的生存率。
Cancers (Basel). 2019 Oct 28;11(11):1668. doi: 10.3390/cancers11111668.
4
ERα is required for suppressing OCT4-induced proliferation of breast cancer cells via DNMT1/ISL1/ERK axis.ERα 通过 DNMT1/ISL1/ERK 轴抑制 OCT4 诱导的乳腺癌细胞增殖是必需的。
Cell Prolif. 2019 Jul;52(4):e12612. doi: 10.1111/cpr.12612. Epub 2019 Apr 22.
5
Ionizing radiation-induced growth in soft agar is associated with miR-21 upregulation in wild-type and DNA double strand break repair deficient cells.电离辐射诱导软琼脂生长与野生型和 DNA 双链断裂修复缺陷细胞中 miR-21 的上调有关。
DNA Repair (Amst). 2019 Jun;78:37-44. doi: 10.1016/j.dnarep.2019.03.012. Epub 2019 Mar 23.
6
Rhamnetin induces apoptosis in human breast cancer cells via the miR-34a/Notch-1 signaling pathway.鼠李素通过miR-34a/Notch-1信号通路诱导人乳腺癌细胞凋亡。
Oncol Lett. 2019 Jan;17(1):676-682. doi: 10.3892/ol.2018.9575. Epub 2018 Oct 15.
7
The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo.超声辐射对体外和体内 P-糖蛋白介导的多药耐药的影响。
J Exp Clin Cancer Res. 2018 Sep 19;37(1):232. doi: 10.1186/s13046-018-0900-6.
8
OCT4B regulates p53 and p16 pathway genes to prevent apoptosis of breast cancer cells.OCT4B调节p53和p16通路基因以防止乳腺癌细胞凋亡。
Oncol Lett. 2018 Jul;16(1):522-528. doi: 10.3892/ol.2018.8607. Epub 2018 May 2.
9
Cardamonin reduces chemotherapy resistance of colon cancer cells via the TSP50/NF-κB pathway .小豆蔻明通过TSP50/NF-κB通路降低结肠癌细胞的化疗耐药性。
Oncol Lett. 2018 Jun;15(6):9641-9646. doi: 10.3892/ol.2018.8580. Epub 2018 Apr 26.
10
Decoding the Emerging Patterns Exhibited in Non-coding RNAs Characteristic of Lung Cancer with Regard to their Clinical Significance.解码肺癌非编码RNA所呈现的新出现模式及其临床意义。
Curr Genomics. 2018 May;19(4):258-278. doi: 10.2174/1389202918666171005100124.
Cancer Res. 2012 Nov 1;72(21):5576-87. doi: 10.1158/0008-5472.CAN-12-2001. Epub 2012 Sep 10.
4
Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer.p63 及其 microRNA-205 靶基因的缺失导致前列腺癌中细胞迁移和转移的增强。
Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15312-7. doi: 10.1073/pnas.1110977109. Epub 2012 Sep 4.
5
MicroRNA-21 modulates the levels of reactive oxygen species by targeting SOD3 and TNFα.MicroRNA-21 通过靶向 SOD3 和 TNFα 调节活性氧水平。
Cancer Res. 2012 Sep 15;72(18):4707-13. doi: 10.1158/0008-5472.CAN-12-0639. Epub 2012 Jul 25.
6
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme.miR-34a 通过调节胶质母细胞瘤中的 EGFR 发挥肿瘤抑制作用。
Oncogene. 2013 Feb 28;32(9):1155-63. doi: 10.1038/onc.2012.132. Epub 2012 May 14.
7
p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells.p53 通过调控细胞周期和 microRNAs 促进人胚胎干细胞的分化。
PLoS Biol. 2012;10(2):e1001268. doi: 10.1371/journal.pbio.1001268. Epub 2012 Feb 28.
8
miR-34 miRNAs provide a barrier for somatic cell reprogramming.miR-34 miRNAs 为体细胞重编程提供了一道屏障。
Nat Cell Biol. 2011 Oct 23;13(11):1353-60. doi: 10.1038/ncb2366.
9
Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor.外源性 OCT4 转录因子的传递可生成肿瘤起始细胞。
Breast Cancer Res. 2011 Sep 27;13(5):R94. doi: 10.1186/bcr3019.
10
Residual embryonic cells as precursors of a Barrett's-like metaplasia.残留胚胎细胞作为 Barrett 样化生的前体细胞。
Cell. 2011 Jun 24;145(7):1023-35. doi: 10.1016/j.cell.2011.05.026.